Active Biotech AB【0GQU】銘柄情報

Active Biotech AB (0GQU) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.85

( - )

買値

27.26

売値

29.54

出来高

0.00

平均取引量 (3 か月)

SEK 243,059

財務取引量

0.00 日の範囲 0.00

2.85 52 週間の範囲 2.85

時価総額

75.128M

企業価値

90.466M

前日終値

2.85

始値

時刻

(O)

最終取引時間

VWAP

歳入

純利益

-34.72M

発行済株式数

26,360,671

浮動株比率 (%)

77.67%

機関投資家保有比率 (%)

7.29%

配当利回り

PER

-2.54

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-2.15

ベータ

1.36

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematologi... Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden. 詳細を表示

セクター

Health Care

業界

ウェブサイト

www.activebiotech.com

本社

Lund, Sweden

設立

1983

Active Biotech AB is listed in the Health Care sector of the ロンドン証券取引所 with ticker 0GQU. The last closing price for Active Biotech AB was SEK2.85. Over the last year, Active Biotech AB shares have traded in a share price range of SEK 2.85 to SEK 2.85.

Active Biotech AB currently has 26,360,671 shares in issue. The market capitalisation of Active Biotech AB is SEK75.13 million. Active Biotech AB has a price to earnings ratio (PE ratio) of -2.54.